Mount Sinai Hospital
Toronto, Ontario, M5G1X5, Canada
NCT Number: NCT05361512
The prevalence of obesity has increased worldwide, and the anesthetic care of patients with obesity remains a challenge for providers despite advances. Obesity during pregnancy is a risk factor for hypertensive disorders, gestational diabetes, emergency cesarean section and higher prevalence of difficult airway. Neuraxial techniques should always be preferred in women with obesity, particularly in those with body mass index (BMI) ≥50 kg/m2, where complications can be magnified. It is estimated an overall epidural failure rate of 4.3% in patients with obesity and an epidural failure rate of 13.7% in those with BMI ≥50 kg/m2. Hence, a confirmatory test of epidural catheter placement should prove useful in this patient population. The epidural electrical stimulation test (EEST) and the epidural waveform analysis are tests described in the literature as confirmatory methods for accuracy of placement of the epidural catheter.
The Tsui test has been well studied in obstetric patients, including required threshold electric currents and muscle contraction patterns. However, these studies have been conducted in patients receiving lumbar epidural catheters. Furthermore, they have not specifically included women with obesity class 3, particularly those with BMI≥50 kg/m2. In a recent study conducted in our department, the investigators have observed that patients with BMI≥50 kg/m2 require placement of an epidural catheter at a low-thoracic or high lumbar interspace, to allow the provision of effective surgical anesthesia for cesarean delivery, which often requires a modified incision, either transverse supra-umbilical or infra-umbilical. There are only few studies with waveform confirmation in obstetric patients showing conflicting results and certainly no studies under the circumstances described above. Finally, the Tsui test and the epidural waveform analysis have never been compared in the obstetric population.
The investigators aim to describe the characteristics of the Tsui test and of the epidural waveform analysis in parturients with BMI≥50 kg/m2 receiving epidural catheter placement at T12-L1 for both labor analgesia or anesthesia for cesarean delivery
Looking for future studies?
Notify Me18 year–55 year
Female
Observational
Toronto, Ontario, M5G1X5, Canada
The Tsui test has been well studied in obstetric patients, including required threshold electric currents and muscle contraction patterns. However, these studies have been conducted in patients receiving lumbar epidural catheters. Furthermore, they have not specifically included women with obesity class 3, particularly those with BMI≥50 kg/m2. In a recent study conducted in our department, the investigators have observed that patients with BMI≥50 kg/m2 require placement of an epidural catheter at a low-thoracic or high lumbar interspace, to allow the provision of effective surgical anesthesia for cesarean delivery, which often requires a modified incision, either transverse supra-umbilical or infra-umbilical. There are only few studies with waveform confirmation in obstetric patients showing conflicting results and certainly no studies under the circumstances described above. Finally, the Tsui test and the epidural waveform analysis have never been compared in the obstetric population.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The stimulator is set at frequency of 1Hz with 0.2 msec pulse width and the current output ranging from 0 to 20 mA. The current output will be carefully increased from zero until motor activity is detected up to a maximum of 20 mA.
Other names: epidural electrical stimulation test (EEST)
A pressurized 500ml normal saline bag will be connected to a pressure transducer kit and the transducer will be connected to a portable monitor with the scale set at 0-40 mmHg or to optimum scale. The transducer will be levelled with the heart approximated at the patient's manubrio-sternal angle, with the patient in the sitting position. Sterile tubing will be connected to the epidural needle and attached to transducer. The tubing connection will be filled with saline to ensure proper reflection of the pressure transducer tracing. Test will be considered positive in case of pulsatile waveform is observed in synchrony with heart rate.
Time frame: 15 minutes
Tsui test motor response will be recorded as either: left, right or bilateral. Any increase in current requirement after the test dose will be recorded.
Time frame: 15 minutes
A positive epidural waveform test through the catheter, defined as the presence of a pulsatile waveform observed in synchrony with heart rate: yes or no.
Time frame: 15 minutes
A positive epidural waveform test though the needle, defined as the presence of a pulsatile waveform observed in synchrony with heart rate: yes or no
Time frame: 15 minutes
Tsui test motor response will be recorded as either: left, right or bilateral.
Time frame: 15 minutes
Minimal electrical current required to produce a muscular contraction (mA) at baseline.
Time frame: 15 minutes
Minimal electrical current required to produce a muscular contraction (mA) 5 minutes after the test dose.
Time frame: 15 minutes
Laterality of the Tsui test, recorded as: unilateral right or left, or bilateral
Time frame: 15 minutes
Muscle group responding to the electrical stimulation: abdominal wall, thigh, lower leg, foot (left or right)
Time frame: 15 minutes
The need for catheter mobilization, including replacement (at any time after it is placed) will be documented as yes or no. The reason will also be recorded.
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05155826
Delivery Problem, Dystocia
Saint-Etienne, France
View Trial DetailsNCT07647809
Back Pain, Depression, Postpartum
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06304311
Labor Pain, Neurologic Manifestations
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05606952
Labor Pain, Neurologic Manifestations
Menoufia, Egypt
View Trial Details